However, there was no significant difference in GOLT1B expression between tumor and normal tissues for adrenocortical carcinoma (ACC), acute myeloid leukemia (LAML), brain lower grade glioma (LGG), ovarian serous cystadenocarcinoma (OV), sarcoma (SARC), or uterine carcinosarcoma (UCS). This evidence concerns the gene GOLT1B and sarcoma.